Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Bisphosphonates Class Label Change

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – January 2011

  • Actonel (risedronate sodium) tablets
  • Actonel with Calcium (risedronate sodium with calcium carbonate tablets)
  • Atelvia (risedronate sodium) delayed-release tablets
  • Boniva (ibandronate sodium) tablets
  • Fosamax (alendronate sodium) tablets and oral solution
  • Fosamax Plus D (alendronate sodium/cholecalciferol) Tablets
  • Reclast (zoledronic acid) Injection

 

Summary View

5 WARNINGS AND PRECAUTIONS

5.5 Atypical Subtrochanteric and Diaphyseal Femoral Fractures
  • Atypical, low-energy, or low trauma  fractures of the femoral shaft have been reported in bisphosphonate-treated  patients. These fractures can occur anywhere in the femoral shaft from just.....

MEDICATION GUIDE (new)

-
-